Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2020 Jun 25;10:10662. doi: 10.1038/s41598-020-67556-8

Author Correction: Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1/2 pathway

Kanika Singh 1, Ankit Gupta 1, Ashish Sarkar 1, Ishita Gupta 1,3, Santanu Rana 2, Sagartirtha Sarkar 2, Sameena Khan 1,
PMCID: PMC7314792  PMID: 32581244

Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-57379-7, published online 17 January 2020

This Article contains errors.

In Figure 5A, the orientation of GADPH blot for P-TAK1 is incorrect. In addition, width of Figure 5B has been adjusted. The correct Figure 5 appears below, as Figure 1.

Figure 1.

Figure 1

.

In Figure 6D1, the GADPH blot for SMAD4 was inadvertently duplicated from the SMAD3 western. In addition, the graph for Figure 6D2 is incorrect. The correct Figure 6 appears below, as Figure 2.

Figure 2.

Figure 2

.

In Supplementary Figure S9, the GADPH blot for SMAD4 was inadvertently duplicated from the SMAD3 western. The correct Figure S9 appears below, as Figure 3.

Figure 3.

Figure 3

.

In Figure 7, Figure 7B2 is presented as Figure 7C, and no graph is shown for Figure 7B2. The correct Figure 7 appears below, as Figure 4.

Finally in the legend of Figure 8, the text,

Figure 4.

Figure 4

.

“Knockdown of ATE1 promoted cardiac apoptosis”.

should read:

“Knockdown of ATE1 mitigates cardiac apoptosis”.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES